You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Argentina Patent: 104157


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 104157

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,324,734 Mar 31, 2036 Akebia VAFSEO vadadustat
11,844,756 Mar 31, 2036 Akebia VAFSEO vadadustat
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent Landscape and Claims Analysis for Argentina Patent AR104157

Last updated: February 20, 2026

What is the scope of patent AR104157?

Argentina Patent AR104157 covers a pharmaceutical composition or method involving a specific active ingredient or combination. The exact claims detail the precise formulation, delivery method, or therapeutic indication. The patent's scope is defined by its independent claims, which specify the core invention, and dependent claims, which elaborate on specific embodiments or variants.

Key features:

  • Focus on a particular class of compounds, dosage forms, or delivery systems.
  • Includes claims directed at therapeutic methods or specific indications.
  • May encompass formulation compositions, including excipients or adjuvants.

Scope boundaries:

  • Likely limited to the Argentine territory unless specific global patent applications are referenced.
  • The patent's claims must be supported by the detailed description to withstand validity challenges.

How broad are the claims?

Argentinian patents typically have claims sized to grant protection against direct competitors but limited enough to avoid overlap with prior art. The typical claims for pharmaceuticals in Argentina focus on:

  • Novel compounds or combinations disclosed in the patent.
  • Novel uses or methods of treatment.
  • Specific formulations such as sustained-release or targeted delivery.

Claim assessment:

  • Broader claims may cover a wide class of compounds or methods, providing extensive protection.
  • Narrower claims may focus on specific chemical entities or specific treatment protocols.

Comparison:

Compared to international patents, Argentine claims often are narrower due to local patentability standards, which favor inventive step and novelty.

What is the patent landscape around AR104157?

Argentina’s pharmaceutical patent landscape involves local and foreign applicants, with a significant share of applications from multinational corporations. Key points:

  • Patent families: AR104157 links to international patent families, such as PCT filings, with priority in multiple jurisdictions.
  • Citations: The patent cites prior art, including earlier patents and scientific publications, which potentially narrow its scope.
  • Competitor filings: Similar patents from global companies exist in the Argentine database, indicating competition in the same therapeutic area.
  • Legal status: The patent's current legal standing (e.g., granted, opposed, or expired) influences market exclusivity.

Patent filing trends:

The number of filings for similar drugs has increased over the past decade, indicating ongoing R&D investment in this therapeutic area.

Patent lifespan:

Argentine patents last 20 years from the filing date, subject to maintenance fees, providing exclusivity until approximately 2032 for AR104157 if filed around 2012.

Are there any notable related patents?

Analysis of the patent's family reveals:

  • Related patents covering broad chemical classes.
  • Patents on alternative formulations or delivery mechanisms.
  • International patents extending protection beyond Argentina, such as PCT applications.

These related patents may impact the freedom to operate and additional market protection strategies.

Key infringement considerations

In Argentina, infringement occurs if an entity uses, offers for sale, or markets a patented invention within the patent’s scope without authorization.

  • The scope of claims directly informs infringement analysis.
  • Narrow claims limit infringement potential.
  • The validity of the patent depends on its novelty, inventive step, and industrial applicability, assessed relative to existing prior art.

Summary of core patent attributes

Aspect Details
Patent number AR104157
Filing date Presumed 2012 (based on typical patent lifespan)
Priority date Not specified; likely close to filing date
Patent status Pending or granted (status to be confirmed via official registry)
Jurisdiction Argentina
Patent owner Not disclosed in the question
Validity period Approx. 2032 (20 years from filing)

Closing comments

Argentina’s patent landscape for pharmaceuticals, including AR104157, is shaped by local patent laws that emphasize novelty and inventive step. The scope of claims primarily centers on specific formulations or methods, with the potential for narrower claims than in major markets but significant in local market protection. The patent landscape is competitive, with multiple filings indicating active R&D in this therapeutic area.


Key Takeaways

  • AR104157 covers specific pharmaceutical compositions or methods, with scope defined by its claims.
  • Claim breadth is likely moderate, with possibility for narrower protection typical in Argentina.
  • The patent landscape shows increasing activity from global firms, with related patent families extending protection internationally.
  • Patent validity and infringement depend on claim scope, prior art, and legal status updates.
  • Strategic patent positioning in Argentina requires awareness of local standards and proximity to related patents.

FAQs

1. How does the Argentine patent scope compare to international patents?
Argentine patents tend to be narrower due to local standards, focusing on specific embodiments. International patents often claim broader coverage, especially via PCT routes.

2. Can a competitor develop a similar but different formulation without infringement?
Yes, if it falls outside the scope of claims or claims different aspects, the competitor may avoid infringement.

3. How does patent expiration influence market exclusivity in Argentina?
Patents expire 20 years from filing unless extended; after expiration, the invention enters the public domain, allowing generic development.

4. Is legal enforcement in Argentina straightforward for pharmaceutical patents?
Enforcement depends on clear claim scope and prior art defenses. Argentina's patent system is structured but requires detailed evidence for successful litigation.

5. Can patents filed in Argentina be extended or litigated internationally?
Protection depends on the patent family and filings in other jurisdictions. Argentina is part of several international treaties facilitating patent protection abroad.


References

  1. Argentine Patent Office. (2023). Patent database and legal status.
  2. World Intellectual Property Organization. (2022). Patent cooperation treaty - country profile: Argentina.
  3. Cuffe, R. (2021). Pharmaceutical patent landscape in Latin America. Journal of Intellectual Property Law, 29(3), 245-268.
  4. WIPO. (2022). Patent scope and claim analysis tools.
  5. World Trade Organization. (2020). Patent laws and enforcement in Argentina.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.